laryngeal tube ventilation and continuous chest compression
DeviceComparison of no flow time between two strategies in out of hospital cardiac arrest
Other names: Laryngeal Tube LTD, VBM
NCT Number: NCT01295749
International recommendations stress on the importance of no flow time reduction in cardiac arrest management. In fact, no flow time is an independent factor of morbidity and mortality.
In France, cardiac arrests are treated by first responders (including emergency nurses) before the arrival of a mobile intensive care unit. Those first responders use bag-valve-mask for ventilation and therefore practice conventional CPR (30 chest compression / 2 ventilation rhythm). Laryngeal tube is a safe and efficient device in cardiac arrest ventilation. The purpose of our study is to compare the no flow time between two strategies of out of hospital cardiac arrest management by first responders: conventional CPR with bag-valve-mask ventilation vs. compression only CPR with Laryngeal Tube ventilation.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
SDIS, Fontaine, Isere, France
Multicentric, prospective, controlled, randomized study with parallel groups in single blind.
Patients will be included in chronological periods to avoid selection biais (one month with the first medical device the next month with the other one). The determination of these periods will be centralized. The emergency vehicles will be supplied sufficiently with devices. This design has been chosen in order to answer to the emergency problem.
Patients will be included and ventilated by paramedical staff (first responders) before medical staff (Mobile Intensive Care Unit) intervention. Complete detailed information will be given to the patient or to the family and consent asked.
The comparison of no flow time between the two strategies in out of hospital cardiac arrest will be the following :
A : ventilation by bag valve mask and interrupted chest compression B : ventilation by laryngeal tube and continuous chest compression
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Comparison of no flow time between two strategies in out of hospital cardiac arrest
Other names: Laryngeal Tube LTD, VBM
Time frame: arrival of paramedical staff T0
group A : ventilation by bag valve mask and interrupted chest compression group B : ventilation by laryngeal tube and continuous chest compression
outcome measure : time of no flow during Resuscitation by trained paramedical staff in out of hospital cardiac arrest
Time frame: during cardiac arrest at T0
No flow proportion during resuscitation by paramedical staff after emergency training
Time frame: during cardiac arrest at T0
no flow proportion on total resuscitation duration
Time frame: during cardiac arrest at T0
number of failure installation after 2 tests
Time frame: during cardiac arrest at T0
Time of device installation
Time frame: during cardiac arrest at T0
chest expansion during insuflation (yes/no)
Time frame: during cardiac arrest at T0
Mortality : spontaneous cardiac activity recovery, hospital admission, reanimation service or hospital exit date, survival at 28 days , CPC evaluation for patients alive
Time frame: during cardiac arrest at T0
incident during ventilation :
obstruction number of manipulations to optimize ventilation
Time frame: during cardiac arrest at T0
ETCO2
Time frame: during cardiac arrest at T0
Number of external electric shocks
Time frame: during cardiac arrest a T0
degradation due to technical manipulations
University Hospital, Grenoble
Other
Reduction of no Flow Time During Out of Hospital Cardiac Arrest by Using Laryngeal Tube for Airway Management by Nurses.
Acronym: FLOWERS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04366297
COVID-19, Cardiac Arrest
Warsaw, Poland
View Trial DetailsNCT02450071
Airway Obstruction, Brain Diseases
Gothenburg, VästraGötaland, Sweden
View Trial DetailsNCT01502111
Airway Obstruction, Cardiac Arrest
Drøbak, Norway
View Trial DetailsNCT01009606
Cardiac Arrest, Cardiovascular Diseases
Bobigny, Île-de-France Region, France
View Trial Details